CLN3 and juvenile neuronal ceroid lipofuscinosis: We have shown previously that intracerebroventricular (ICV) delivery of an ASO that induces Cln3 exon 5 skipping during pre-mRNA splicing is therapeutic in a mouse model of CLN3 Batten disease, decreasing abnormal histopathology throughout the brain and improving sensorimotor coordination [16].